Unknown

Dataset Information

0

Clonal Dissemination of Clinical Carbapenem-Resistant Klebsiella pneumoniae Isolates Carrying fosA3 and bla KPC-2 Coharboring Plasmids in Shandong, China.


ABSTRACT: Treatment strategies of infection by carbapenem-resistant Klebsiella pneumoniae (CRKP) are limited. Fosfomycin, a broad-spectrum antibiotic, has attracted renewed interest in combination therapy to fight K. pneumoniae infections. However, reports on fosfomycin-resistant K. pneumoniae are increasing. Among the 57 CRKP strains, 40 (70.2%) were resistant to fosfomycin. Thus, whole-genome sequencing and bioinformatics analysis were conducted to reveal molecular characteristics of fosfomycin-resistant K. pneumoniae. Twenty-three isolates coharbored fosA kp and fosA3, with K. pneumoniae carbapenemase (KPC)-producing ST11-KL64-wzi64-O2 (n = 13) and ST11-KL47-wzi209-OL101 (n = 8), the predominating clonal groups, while fosA3 was not detected in isolates carrying class B carbapenemase genes. Twenty-two (out of 26) ST11-KL64 strains were positive for rmpA2, of which 12 carried fosA3. Four of the 23 fosA3-positive isolates could successfully transfer their fosfomycin-resistant determinants to Escherichia coli J53Azi R . All four strains belonged to ST11-KL47 with the same pulsed-field gel electrophoresis profile, and their transconjugants acquired fosfomycin, carbapenem, and aminoglycoside resistance. A 127-kb conjugative pCT-KPC-like hybrid plasmid (pJNKPN52_KPC_fosA) coharboring fosA3, bla KPC-2, bla CTX-M-65, bla SHV-12, rmtB, and bla TEM-1 was identified. ST11-KL64 and ST11-KL47 K. pneumoniae, with higher resistance and virulence, should be critically monitored to prevent the future dissemination of resistance.

SUBMITTER: Hao Y 

PROVIDER: S-EPMC8718808 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clonal Dissemination of Clinical Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Isolates Carrying <i>fosA3</i> and <i>bla</i> <sub><i>KPC</i>-2</sub> Coharboring Plasmids in Shandong, China.

Hao Yingying Y   Zhao Xuguang X   Zhang Cui C   Bai Yuanyuan Y   Song Zhen Z   Lu Xinglun X   Chen Ran R   Zhu Yaoyao Y   Wang Yueling Y  

Frontiers in microbiology 20211217


Treatment strategies of infection by carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP) are limited. Fosfomycin, a broad-spectrum antibiotic, has attracted renewed interest in combination therapy to fight <i>K. pneumoniae</i> infections. However, reports on fosfomycin-resistant <i>K. pneumoniae</i> are increasing. Among the 57 CRKP strains, 40 (70.2%) were resistant to fosfomycin. Thus, whole-genome sequencing and bioinformatics analysis were conducted to reveal molecular characteristics o  ...[more]

Similar Datasets

| S-EPMC7516988 | biostudies-literature
| S-EPMC6526029 | biostudies-literature
| S-EPMC10076803 | biostudies-literature
| S-EPMC6435834 | biostudies-literature
| S-EPMC7012882 | biostudies-literature
| S-EPMC10214462 | biostudies-literature
| S-EPMC9762261 | biostudies-literature
| S-EPMC8421773 | biostudies-literature
| S-EPMC9304888 | biostudies-literature